المؤلفون: Baljozović, M., Arnoldi, B., Grass, S., Lacour, J., Aeschlimann, M., Stadtmüller, B., Ernst, K.-H.

المصدر: Journal of Chemical Physics; 7/28/2023, Vol. 159 Issue 4, p1-8, 8p

مصطلحات موضوعية: PHOTOELECTRON spectroscopy, COPPER, SPIN polarization, PHOTOEMISSION, TIME-resolved spectroscopy, PROOF of concept, COPPER surfaces, CHIRALITY

المؤلفون: Fernandez, A. P., Dauden, E., Gerdes, S., Lebwohl, M. G., Menter, M. A., Leonardi, C. L., Gooderham, M., Gebauer, K., Tada, Y., Lacour, J. P., Bianchi, L., Egeberg, A., Pau-Charles, I., Mendelsohn, A. M., Rozzo, S. J., Mehta, N. N.

المصدر: Fernandez , A P , Dauden , E , Gerdes , S , Lebwohl , M G , Menter , M A , Leonardi , C L , Gooderham , M , Gebauer , K , Tada , Y , Lacour , J P , Bianchi , L , Egeberg , A , Pau-Charles , I , Mendelsohn , A M , Rozzo , S J & Mehta , N N 2022 , ' Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome : post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2 ....

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1111/jdv.18167Test
https://curis.ku.dk/portal/da/publications/tildrakizumab-efficacy-and-safety-in-patients-with-psoriasis-and-concomitant-metabolic-syndromeTest(1b2f11d6-0000-49c4-b600-9d01dff26d40).html
https://curis.ku.dk/ws/files/319577463/Acad_Dermatol_Venereol_2022_Fernandez_Tildrakizumab_efficacy_and_safety_in_patients_with_psoriasis_and_concomitant.pdfTest

المؤلفون: Ständer, S., Yosipovitch, G., Lacour, J.‐P., Legat, F.J., Paul, C., Reich, A., Chaouche, K., Ahmad, F., Piketty, C.

المصدر: Journal of the European Academy of Dermatology and Venereology ; volume 36, issue 10, page 1820-1825 ; ISSN 0926-9959 1468-3083

الإتاحة: https://doi.org/10.1111/jdv.18377Test

المؤلفون: Dryhynycz, V., Lavandier, K., Douarinou, M., Mione, G., Humbertjean, L., Lacour, J.-C., Gory, B., Richard, S.

المصدر: Pratique Neurologique - FMC ; volume 13, issue 1, page 28-32 ; ISSN 1878-7762

مصطلحات موضوعية: Neurology (clinical)

الإتاحة: https://doi.org/10.1016Test/j.praneu.2021.12.013
https://api.elsevier.com/content/article/PII:S1878776221001333?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1878776221001333?httpAccept=text/plainTest

المؤلفون: Sumodhee, S., Guo, L., Bouhlel, L., Picard, A., Otto, J., Naghavi, A.O., Richier, Q., Lévy, A., Bondiau, P.-Y., Poudenx, M., Passeron, T., Lacour, J.-P., Montaudié, H., Doyen, J.

المصدر: Cancer/Radiothérapie ; volume 26, issue 8, page 1045-1053 ; ISSN 1278-3218

مصطلحات موضوعية: Radiology, Nuclear Medicine and imaging, Oncology

الإتاحة: https://doi.org/10.1016Test/j.canrad.2022.04.005
https://api.elsevier.com/content/article/PII:S1278321822000932?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1278321822000932?httpAccept=text/plainTest

المؤلفون: Lacour, J.-L. (Jacques Louis)

الوصول الحر: https://www.europeana.eu/item/2059209/data_sounds_ark__81055_vdc_00000002D246?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCaTest

المؤلفون: Lacour, J.-J.

الوصول الحر: https://www.europeana.eu/item/9200520/ark__12148_bpt6k5692404k?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCaTest

المؤلفون: Lacour, J.-J.. Auteur du texte

الوصول الحر: https://www.europeana.eu/item/9200520/12148_bpt6k5692404k?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCaTest

المؤلفون: Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E., Worm, M., Lynde, C., Lacour, J., Spelman, L., Katoh, N., Saeki, H., Poulin, Y., Lesiak, A., Kircik, L., Cho, S.H., Herranz, P., Cork, M.J., Peris, K., Steffensen, L.A., Bang, B., Kuznetsova, A., Jensen, T.N., Østerdal, M.L., Simpson, E.L.

وصف الملف: text

العلاقة: https://eprints.whiterose.ac.uk/166500/7/Br%20J%20Dermatol%20-%202020%20-%20Wollenberg%20-%20Tralokinumab%20for%20moderate%E2%80%90to%E2%80%90severe%20atopic%20dermatitis%20%20results%20from%20two%2052%E2%80%90week%20.pdfTest; Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E. et al. (19 more authors) (2021) Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2). British Journal of Dermatology, 184 (3). pp. 437-449. ISSN 0007-0963

الإتاحة: https://eprints.whiterose.ac.uk/166500Test/
https://eprints.whiterose.ac.uk/166500/7/Br%20J%20Dermatol%20-%202020%20-%20Wollenberg%20-%20Tralokinumab%20for%20moderate%E2%80%90to%E2%80%90severe%20atopic%20dermatitis%20%20results%20from%20two%2052%E2%80%90week%20.pdfTest

المؤلفون: Seneschal, J., Lacour, J.‐P., Bewley, A., Faurby, M., Paul, C., Pellacani, G., De Simone, C., Horne, L., Sohrt, A., Augustin, M., Hammond, E., Reich, K.

المساهمون: LEO Pharma Research Foundation, Amgen, AstraZeneca

المصدر: Journal of the European Academy of Dermatology and Venereology ; volume 34, issue 11, page 2566-2573 ; ISSN 0926-9959 1468-3083

الإتاحة: https://doi.org/10.1111/jdv.16568Test